Clinical & Experimental Allergy, 2022
Exploring proteomic plasma biomarkers in eosinophilic and neutrophilic asthma

Kere M., Klevebro S., Hernandez‐Pacheco N. et al.

Journal of Critical Care, 2022
Cystatin C and derived measures of renal function as risk factors for mortality and acute kidney injury in sepsis – A post-hoc analysis of the FINNAKI cohort

Linné E., Elfström A., Åkesson A. et al.

Nature Cardiovascular Research, 2022
Age-dependent sex differences in cardiometabolic risk factors

Zhernakova D., Sinha T., Andreu-Sánchez S. et al.

ESC Heart Failure, 2022
Insulin‐like growth factor binding protein 7 (IGFBP7), a link between heart failure and senescence

Bracun V., van Essen B., Voors A. et al.

ESC Heart Failure, 2022
Elevated plasma WIF‐1 levels are associated with worse prognosis in heart failure with pulmonary hypertension

Kania K., Ahmed A., Ahmed S. et al.

Diabetes, Obesity and Metabolism, 2022
External validation and extension of the TIMI risk score for heart failure in diabetes for patients with recent acute coronary syndrome: An analysis of the EXAMINE trial

Razaghizad A., Sharma A., Ni J. et al.

Journal of Neuroinflammation, 2022
Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses

Pfeuffer S., Rolfes L., Wirth T. et al.

Journal of Clinical Immunology, 2022
Three Adult Cases of STAT1 Gain-of-Function with Chronic Mucocutaneous Candidiasis Treated with JAK Inhibitors

Borgström E., Edvinsson M., Pérez L. et al.

Neurology Neuroimmunology & Neuroinflammation, 2022
Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral Sclerosis

Thonhoff J., Berry J., Macklin E. et al.

International Journal of Cancer, 2022
A novel serum extracellular vesicle protein signature to monitor glioblastoma tumor progression

Tzaridis T., Weller J., Bachurski D. et al.

Gut, 2022
Distinct blood protein profiles associated with the risk of short-term and mid/long-term clinical relapse in patients with Crohn’s disease stopping infliximab: when the remission state hides different types of residual disease activity

Pierre N., Huynh-Thu V., Marichal T. et al.

Science Advances, 2022
Proteomic profiling platforms head to head: Leveraging genetics and clinical traits to compare aptamer- and antibody-based methods

Katz D., Robbins J., Deng S. et al.

Molecular Psychiatry, 2022
Cerebrospinal fluid proteomic study of two bipolar disorder cohorts

Isgren A., Göteson A., Holmén-Larsson J. et al.

Physiological Reports, 2022
Quantifying the inflammatory secretome of human intermuscular adipose tissue

Kahn D., Macias E., Zarini S. et al.

Journal of Clinical Immunology, 2022
SOCS1 Haploinsufficiency Presenting as Severe Enthesitis, Bone Marrow Hypocellularity, and Refractory Thrombocytopenia in a Pediatric Patient with Subsequent Response to JAK Inhibition

Michniacki T., Walkovich K., DeMeyer L. et al.

Nature Communications, 2022
ELF5 is a potential respiratory epithelial cell-specific risk gene for severe COVID-19

Pietzner M., Chua R., Wheeler E. et al.

Nordic Journal of Psychiatry, 2022
Intercorrelation of physiological seizure parameters and hormonal changes in electroconvulsive therapy

Thörnblom E., Gingnell M., Cunningham J. et al.

Multiple Sclerosis and Related Disorders, 2022
High-intensity resistance training in people with multiple sclerosis experiencing fatigue: A randomised controlled trial

Englund S., Piehl F., Kierkegaard M.

Journal of Molecular and Cellular Cardiology Plus, 2022
Serial measurements of protein and microRNA biomarkers to specify myocardial infarction subtypes

Schulte C., Singh B., Theofilatos K. et al.

Nature Cardiovascular Research, 2022
Identification of LTBP-2 as a plasma biomarker for right ventricular dysfunction in human pulmonary arterial hypertension

Boucherat O., Yokokawa T., Krishna V. et al.